This paper is in the following e-collection/theme issue:

Mobile Health (mhealth) (2765) Quality Evaluation and Descriptive Analysis/Reviews of Multiple Existing Mobile Apps (362) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1309) Chronic Conditions (216) Immunology, Allergy, Rheumatology (78) mHealth for Patient Education (214)

Published on in Vol 24, No 3 (2022): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/31016, first published .
The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search

The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search

The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search

Authors of this article:

Rosa Romero-Jimenez1 Author Orcid Image ;   Vicente Escudero-Vilaplana1 Author Orcid Image ;   Esther Chamorro-De-Vega1 Author Orcid Image ;   Arantza Ais-Larisgoitia1 Author Orcid Image ;   Maria Elena Lobato Matilla1 Author Orcid Image ;   Ana Herranz-Alonso1 Author Orcid Image ;   Maria Sanjurjo1 Author Orcid Image
Article Authors Cited by (2) Tweetations (14) Metrics

Journals

  1. Chamorro-de-Vega E, Romero-Jiménez R, Escudero-Vilaplana V, Ais-Larisgoitia A, Lobato Matilla M, González C, Menchén L, Baniandrés O, Ibares-Frias L, Lobo-Rodríguez C, Herranz-Alonso A, Sanjurjo M. Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey. Journal of Medical Internet Research 2022;24(9):e37445 View
  2. Romero-Jimenez R, Escudero-Vilaplana V, Chamorro-de-Vega E, Ais-Larisgoitia A, Lobato-Matilla E, Somoza-Fernández B, Ruiz-Briones P, González C, Baniandrés O, Menchén L, Lobo-Rodríguez C, Herranz A, Sanjurjo M. Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare. Frontiers in Immunology 2022;13 View